WEDNESDAY, July 24, 2019 (HealthDay News) -- Metformin use is associated with a substantially lower risk for dementia among younger African-American patients with diabetes compared with
sulfonylurea initiation, according to a study published in the July/August issue of the Annals of Family Medicine.
Metformin is known to reduce TSH (thyroid stimulating hormone) levels, and this property may be beneficial in refractory hypothyroid patients with concomitant diabetes.8 Older
sulfonylureas exhibit a goitrogenic effect, and inhibit the synthesis of thyroid hormone.9 Pioglitazone can cause orbital oedema by increasing IGF1 (insulin like growth factor-1), adipose tissue synthesis and TSH secretion.10 There are reports of increased risk of thyroid malignancy with older
sulfonylurea and certain insulin analogues, but these are not substantiated and do not impact modern clinical practice.11,12 Liraglutide is contraindicated in persons with medullary thyroid carcinoma.13
Sulfonylurea is the treatment of choice in patients with KCNJ11 or ABCC8 mutations (13,25).
The channel contains a regulatory subunit, composed of the ABCC8 or ABCC9 (ATP-binding cassette, subfamily C members 8 and 9) gene products referred to as
sulfonylurea receptor 1 and 2 (SUR1 and SUR2) proteins [2], respectively.
The label was also updated to include results from the AWARD-8 clinical trial, a Phase 3b randomized, double-blind, placebo-controlled, 24-week study that evaluated the efficacy and safety of Trulicity 1.5mg as an add-on to
sulfonylurea compared to placebo plus
sulfonylurea.
Consider a dipeptidyl peptidase-4 inhibitor before a
sulfonylurea for patients with type 2 diabetes mellitus who require therapy in addition to metformin.
If the patient is taking a
sulfonylurea or insulin, the dose may need to be reduced when an SGLT-2 is initiated to avoid hypoglycemia.
Patients with type 2 diabetes mellitus treated with metformin as a monotherapy are at a decreased risk for cardiovascular mortality when compared with those on
sulfonylurea monotherapy.
Patients with type 2 diabetes treated with metformin as a monotherapy are at a decreased risk for cardiovascular mortality, compared with those on
sulfonylurea monotherapy, according to a report in the Annals of Internal Medicine.
Police said, on a tip-off, police raided
Sulfonylurea factory located at Chowk Azam and arrested the owner and four others.